M&A Target Report
Project Aurora — M&A Target Screen
Aurora Cooling (sample target)
- Author
- A. Analyst (sample)
- Date
- 2025-02-20
- Version
- v1.2
- Status
- Draft
- Confidence
- Low
Executive Summary
Aurora is a plausible bolt-on in data-center cooling. Strategic fit is strong; the open questions are price, integration risk, and whether the synergy case survives diligence.
What changed
Target entered the screen after the cooling bottleneck thesis.
Why
Value is migrating toward thermal management.
Who is affected
Acquirer's roadmap and margin profile.
Evidence
Preliminary screen — not diligenced.
Next decision
Decide whether to proceed to formal diligence.
Key Findings
- 1
Strong strategic fit
PositiveFills the thermal gap in the roadmap.
- 2
Integration risk unknown
WatchCulture and systems not yet assessed.
- 3
Price likely full
RiskScarcity of assets could inflate valuation.
Evidence
| Claim | Source | Type | Confidence | Date |
|---|---|---|---|---|
| Cooling demand rising | Industry note | Research | Medium | 2025-01-30 |
Sources
Company filing (FY24)
Sample filing
Filing2025-02-18Earnings call transcript
Investor relations
Transcript2025-02-19Industry note
Sample research
Research2025-01-30
Risks
- OverpaymentL: Medium · I: HighCompetitive process may inflate price.
- Integration failureL: Medium · I: HighSynergies may not materialize.
Opportunities
- Vertical integration — Owning thermal could protect margins.
Assumptions
- Target is willing to engage.
Open Questions
- Does the synergy case survive diligence?
- What price walks away?
Recommendations
Proceed to diligence
Medium priorityStrategic fit justifies a closer look.
Owner: Corp dev
Decision Log
| Date | Decision | Owner | Outcome |
|---|---|---|---|
| 2025-02-20 | Advance to diligence gate | Corp dev | Pending approval |
Appendix
Methodology
Sample methodology note — how findings would be assembled and scored.
Glossary
Definitions of terms used throughout the report.
Version History
- v1.22025-02-20A. Analyst (sample)Refined recommendations after review.
- v1.12025-02-12A. Analyst (sample)Added evidence and risk matrix.
- v1.02025-02-05A. Analyst (sample)Initial draft.